Solasta Ventures, Inc. (formerly known in the U.S. as Aju IB Investment) is a wholly-owned subsidiary of Aju IB Investment, a leading South Korean venture capital firm.

We are committed to investing in innovative companies that advance the standard of care for diseases with unmet medical needs. Our team leverages deep scientific expertise and an extensive network to identify promising therapeutics and discovery platforms that have the potential to transform patients’ lives worldwide.

Tibit Communications

Seer

Rallybio

Rapt Therapeutics

Kezar Life Sciences

Kymera Therapeutics

Carisma Therapeutics

Xilio Therapeutics, Inc.

Apellis Pharmaceuticals

Arcellx

Atea Pharmaceuticals

Solasta Ventures

Solasta Ventures is a venture capital firm that specializes in investing in early-stage technology startups. The firm focuses on companies that are developing breakthrough scientific solutions and disruptive technologies in various sectors such as artificial intelligence, life sciences, and sustainable energy.

COM:SOLASTA-VENTURES

Solasta Ventures

Filings Not Available